Aug 21, 2012 - Practice Guidelines Working Group (9th Edition) and is shown in the supplementary online appendix ..... (
DOI: 10.1161/CIRCULATIONAHA.112.105221
Periprocedural Heparin Bridging in Patients Receiving Vitamin K Antagonists: Systematic Review and Meta-Analysis of Bleeding and Thromboembolic Rates
Running title: Siegal et al.; Periprocedural Bridging Anticoagulation
Downloaded from http://circ.ahajournals.org/ by guest on October 6, 2017
Deborah Siegal, MD, MSc1; Jovana Yudin, MD, BSc1; Scott Kaatz, DO, MSc, FACP2; James D. Douketis, MD, FRCPC1; Wendy Lim, MD, MSc, FRCPC1; Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC3 1
Dept of Medicine, Division of Hematology & Thromboembolism, McMaster University, Hamilton, Ontario, Canada; 2Dept of Medicine, Henry Ford Hospital, Detroit, MI; 3Dept p of Medicine, Division of Hematology/Oncology, University Rochester, Hema He mato ma tolo to logyy/O lo /Onc n ology, James P Wilmot Cancer er C Center, Universi ity y off Ro Roc chester, Rochester, NY
Correspondence: Co orrres e po pond nd den encce: Alex Al ex C S Spy Spyropoulos, pyro py ropo p ul po ulos os,, MD MD,, FACP, FACP FA CP,, FCCP, FCCP FC CP,, FRCPC FRCP FR CPC C Associate Asso As soci ciat atee Pr Prof Professor offes esso sorr off M Medicine ed dicin icinee Division of Hematology/Oncology James P Wilmot Cancer Center University of Rochester Medical Center 601 Elmwood Ave, Box 704 Rochester, NY 14642 Tel: 585 276 6103 Fax: 585 276 0350 E-mail:
[email protected]
Journal Subject Codes: [172] Arterial thrombosis; [173] Deep vein thrombosis; [174] Coagulation; [183] Heparin; [184] Coumarins
1
DOI: 10.1161/CIRCULATIONAHA.112.105221
Abstract: Background - Periprocedural bridging with unfractionated heparin or low molecular weight heparin (LMWH) aims to reduce the risk of thromboembolic (TE) events in patients receiving chronic vitamin K antagonists (VKA). Optimal periprocedural anticoagulation has not been established. Methods and Results - Search of MEDLINE, EMBASE and Cochrane ) 22. limit 21 ("adult (19 to 44 years)" or "young adult and adult (19-24 and 19-44)" or "middle age (45 to 64 years)" or "middle aged (45 plus years)" or "all aged (65 and over)" or "aged (80 and over)") 23. limit 21 to (case reports or clinical conference or comment or congresses or editorial or in vitro or letter) 24. 22 not 23
Supplemental Table 1. Indications for anticoagulation and type of surgical or invasive procedures Author, year
Indications for anticoagulation
Invasive procedure or surgery
Bajkin, 2009 1
Atrial fibrillation
Dental procedures
Mechanical heart valve Venous thromboembolism Ischemic heart disease Stroke Bombuy, 2009
2
Atrial fibrillation
General surgery
Mechanical heart valve Stroke Other Bui, 2009 3
Atrial fibrillation
Abdominal surgery
Mechanical heart valve
Cardiothoracic surgery Dermatologic procedures Endoscopy General surgery Gynecologic surgery Head and neck surgery Orthopedic surgery Neurological procedures Urologic surgery Vascular surgery
Cheng, 2009
4
Constans, 2007
5
Not specified
Cardiac device implantation
Atrial fibrillation
Endoscopy
Mechanical heart valve Venous thromboembolism Myocardial infarction Thrombophilia Systemic embolism Daniels, 2009 6
Not specified
Angiography Biopsies Cardiac procedures
Cardiothoracic surgery Dental procedures Endoscopy General surgery Gynecologic surgery Head and neck surgery Miscellaneous procedures (thoracentesis) Neurological procedures Neurosurgery Ophthalmological surgery Orthopedic surgery Urologic surgery Vascular surgery Dotan, 2002 7
Atrial fibrillation
Urologic surgery
Mechanical heart valve Venous thromboembolism Congestive heart failure Hypercoagulable state Stroke Douketis, 2004
8
Atrial fibrillation
Abdominal surgery
Mechanical heart valve
Angiography
Stroke/TIA
Biopsy Cardiac device implantation Cardiothoracic surgery Dental procedures Dermatological procedures Endoscopy General surgery Gynecologic surgery Head and neck surgery Neurosurgery Ophthalmological surgery Orthopedic surgery Urologic surgery
Vascular surgery Douketis, 2005
9
Atrial fibrillation
Not specified
Mechanical heart valve Venous thromboembolism Dunn, 2007
10
Atrial fibrillation
Abdominal surgery
Venous thromboembolism
Angiography Cardiac device implantation Cardiac procedures Cardiothoracic surgery Dental procedures Dermatological procedures Endoscopy General surgery Gynecologic surgery Head and neck surgery Ophthalmological surgery Orthopedic surgery Urologic surgery
Ercan, 2010 11
Atrial fibrillation
Abdominal surgery
Mechanical heart valve Mitral stenosis Aortic stenosis Peripheral vascular disease Garcia, 2008
12
Atrial fibrillation
Biopsy
Mechanical heart valve
Dental procedures
Stroke
Dermatological procedures
Left ventricular dysfunction
Endoscopy
Other (not specified)
Neurological procedures Ophthalmological surgery Urologic surgery
Ghanbari, 2010
13
Atrial fibrillation
Cardiac device implantation
Mechanical heart valve Halbritter, 2005
14
Atrial fibrillation
Angiography
Mechnical heart valve
Cardiac device implantation
Venous thromboembolism
Endoscopy
Left ventricular dysfunction
General surgery
Other (not specified)
Orthopedic surgery Vascular surgery
Jaffer, 2005 15
Atrial fibrillation
Abdominal surgery
Mechanical heart valve
Angiography
Venous thromboembolism
Biopsy
Thrombophilia
Cardiac device implantation
Stroke
Cardiothoracic surgery
Atrial tachycardia
Dental procedures Dermatological procedures Endoscopy General surgery Gynecologic surgery Ophthalmological surgery Orthopedic surgery Procedures (thoracentesis) Urologic surgery
Jaffer, 2010
16
Atrial fibrillation
Abdominal surgery
Mechanical heart valve
Angiography
Venous thromboembolism
Cardiothoracic surgery
Stroke with patent foramen ovale
Dental procedures
Cryptogenic stroke
Dermatological procedures
Antiphospholipid antibody with thrombosis
Endoscopy
Dilated cardiomyopathy
Head and neck surgery
Multiple indications (not specified)
Ophthalmological surgery
Geneal surgery
Orthopedic surgery Vascular surgery
Kovacs, 2004
17
Atrial fibrillation
Abdominal surgery
Mechanical heart valve
Angiography Biopsy Cardiothoracic surgery Dental procedures Endoscopy General surgery
Ophthalmological surgery Orthopedic surgery Urologic surgery Malato, 2010 18
Atrial fibrillation
Abdominal surgery
Mechanical heart valve
Biopsy
Venous thromboembolism
Dermatological procedures
Arterial hypertension
Endoscopy
Dilated cardiomyopathy
General surgery
Valvulopathy
Gynecologic surgery
Myocardial infarction
Neurosurgery
Coronary artery bypass graft
Orthopedic surgery Urologic surgery
Marquie, 2006
19
McBane, 2010
20
Atrial fibrillation
Cardiac device implantation
Mechanical heart valve Venous thromboembolism
Abdominal surgery Cardiothoracic surgery Dental procedures General surgery Gynecologic surgery Head and neck surgery Interventional radiology Neurosurgery Ophthalmological surgery Orthopedic surgery Plastic surgery Urologic surgery Vascular surgery
O’Donnell, 2007
Pengo, 2009
22
21
Atrial fibrillation
Angiography
Mechanical heart valve
Cardiac device implantation
Venous thromboembolism
Dental procedures
Coronary artery disease
Dermatological procedures
Valvular heart disease
Orthopedic surgery
Other (not specified)
Vascular surgery
Atrial fibrillation
Abdominal surgery
Mechanical heart valve
Angiography
Venous thromboembolism
Biopsies Cardiac device implantation Dermatological procedures Endoscopy General surgery Gynecologic surgery Head and neck surgery Neurosurgery Ophthalmological surgery Orthopedic surgery Urologic surgery Vascular surgery
Robinson, 2009
23
Spyropoulos, 2004a 24
Not specified
Cardiac device implantation
Atrial fibrillation
Abdominal surgery
Mechanical heart valve
Angiography Biopsies Cardiac device implantation Cardiothoracic surgery Dental procedures Endoscopy General surgery Head and neck surgery Neurological procedures Orthopedic surgery Urologic surgery Vascular surgery
Spyropoulos, 2004b25
Mechanical heart valve
Cardiothoracic surgery
Venous thromboembolism
Endoscopy
Other arterial/cardiac disease
General surgery Gynecologic surgery Interventional radiology Ophthalmological surgery Urologic surgery
Spyropoulos, 2006
26
Atrial fibrillation
Cardiothoracic surgery
Mechanical heart valve
Dental procedures
Venous thromboembolism
Dermatological procedures
Other (not specified)
Endoscopy General surgery Gynecologic surgery Head and neck surgery Interventional radiology Ophthalmological surgery Orthopedic surgery Urologic surgery Vascular surgery
Spyropoulos, 2008
27
Mechanical heart valve
Cardiothoracic surgery Dental procedures Dermatological procedures Endoscopy General surgery Gynecologic surgery Head and neck surgery Interventional radiology Ophthalmological surgery Orthopedic surgery Urologic surgery Vascular surgery
Tinmouth, 2001
28
Atrial fibrillation with bioprosthetic valve
Abdominal surgery
Atrial fibrillation with valve disease
Biopsies
Mechanical heart valve Venous thromboembolism
Angiography Dental procedures Dermatological procedures Endoscopy General surgery Gynecologic surgery Ophthalmological surgery Orthopedic surgery Urologic surgery Vascular surgery
Tischenko, 2009 29
Atrial fibrillation
Cardiac device implantation
Prosthetic heart valve Venous thromboembolism Stroke/transient ischemic attack Tompkins, 2010 30 Varkarakis, 2005
31
Not specified
Cardiac device implantation
Atrial fibrillation
Abdominal surgery
Mechanical heart valve Venous thromboembolism Other (not specified) Wazni, 2007 32 Wilson, 2001
33
Atrial fibrillation
Cardiac procedure
Atrial fibrillation
Abdominal surgery
Mechanical heart valve
Angiography
Venous thromboembolism
Dental procedures
Congestive heart failure
Endoscopy General surgery Gynecologic surgery Ophthalmological surgery Orthopedic surgery Urologic surgery Vascular surgery
Wysokinski, 2008
34
Atrial fibrillation
Abdominal surgery Cardiothoracic surgery Dental procedures General surgery Gynecologic surgery Neurosurgery Ophthalmological surgery Orthopedic surgery Other (not specified) Urologic surgery Vascular surgery
Suppleme ntal References 1.
Bajkin BV, Popovic SL, Selakovic SDJ. Randomized, prospective trial comparing bridging therapy using low-molecular-weight heparin with maintenance of oral anticoagulation during extraction of teeth. J Oral Maxillofac Surg. 2009;67:990-995.
2.
Bombuy E, Mans E, Hugue A, Plensa E, Rodriguez L, Prats M, Sunol X. Elective inguinal hernioplasty in patients on chronic anticoagulation therapy. Management and outcome. Cir Esp. 2009;86:38-42.
3.
Bui HT, Krisnaswami A, Le C-U, Chan J, Shenoy B-N. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation. Am J Cardiol. 2009;104:1429-1433.
4.
Cheng M, Hua W, Chen K, Pu J, Ren X, Zhao X, Liu Z, Wang F, Chen X, Zhang S. Perioperative anticoagulation for patients with mechanic heart valve(s) undertaking pacemaker implantation. Europace. 2009;11:1183-1187.
5.
Constans M, Santamaria A, Mateo J, Pujol N, Souto JC, Fontcuberta J. Low-molecular-weight heparin as bridging therapy during interruption of oral anticoagulation in patients undergoing colonoscopy or gastroscopy. Int J Clin Pract. 2007;61:212-217.
6.
Daniels PR, McBane RD, Litin SC, Ward SA, Hodge DO, Dowling NF, Heit JA. Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients. Thromb Res. 2009;124:300-305.
7.
Dotan ZA, Mor Y, Leibovitch I, Varon D, Golomb J, Duvdevani M, Ramon J. The efficacy and safety of perioperative low molecular weight heparin substitution in patients on chronic oral anticoagulant therapy undergoing transurethral prostatectomy for bladder outlet obstruction. J Urol. 2002;168:610-613; discussion 614.
8.
Douketis JD, Johnson JA, Turpie AG. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Arch Intern Med. 2004;164:1319-1326.
9.
Douketis JD, Woods K, Foster GA, Crowther MA. Bridging anticoagulation with low-molecularweight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery. Thromb Haemost. 2005;94:528-531.
10.
Dunn AS, Spyropoulos AC, Turpie AGG. Bridging therapy in patients on long-term oral anticoagulants who require surgery: the Prospective Peri-operative Enoxaparin Cohort Trial (PROSPECT). J Thromb Haemost. 2007;5:2211-2218.
11.
Ercan M, Bostanci EB, Ozer I, Ulas M, Ozogul YB, Teke Z, Akoglu M. Postoperative hemorrhagic complications after elective laparoscopic cholecystectomy in patients receiving long-term anticoagulant therapy. Langenbecks Arch Surg. 2010;395:247-253.
12.
Garcia DA, Regan S, Henault LE, Upadhyay A, Baker J, Othman M, Hylek EM. Risk of thromboembolism with short-term interruption of warfarin therapy. Arch Intern Med. 2008;168:63-69.
13.
Ghanbari H, Feldman D, Schmidt M, Ottino J, Machado C, Akoum N, Wall TS, Daccarett M. Cardiac resynchronization therapy device implantation in patients with therapeutic international normalized ratios. Pacing Clin Electrophysiol. 2010;33:400-406.
14.
Halbritter KM, Wawer A, Beyer J, Oettler W, Schellong SM. Bridging anticoagulation for patients on long-term vitamin-K-antagonists. A prospective 1 year registry of 311 episodes. J Thromb Haemost. 2005;3:2823-2825.
15.
Jaffer AK, Ahmed M, Brotman DJ, Bragg L, Seshadri N, Qadeer MA, Klein A. Low-molecularweight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: A standardized bridging therapy protocol. J Thromb Thrombolysis. 2005;20:11-16.
16.
Jaffer AK, Brotman DJ, Bash LD, Mahmood SK, Lott B, White RH. Variations in perioperative warfarin management: outcomes and practice patterns at nine hospitals. Am J Med. 2010;123:141-150.
17.
Kovacs MJ, Kearon C, Rodger M, Anderson DR, Turpie AGG, Bates SM, Desjardins L, Douketis J, Kahn SR, Solymoss S, Wells PS. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation. 2004;110:1658-1663.
18.
Malato A, Saccullo G, Lo Coco L, Caramazza D, Abbene I, Pizzo G, Casuccio A, Siragusa S. Patients requiring interruption of long-term oral anticoagulant therapy: the use of fixed sub-therapeutic doses of low-molecular-weight heparin. J Thromb Haemost. 2010;8:107-113.
19.
Marquie C, De Geeter G, Klug D, Kouakam C, Brigadeau F, Jabourek O, Trillot N, Lacroix D, Kacet S. Post-operative use of heparin increases morbidity of pacemaker implantation. Europace. 2006;8:283-287.
20.
McBane RD, Wysokinski WE, Daniels PR, Litin SC, Slusser J, Hodge DO, Dowling NF, Heit JA. Periprocedural anticoagulation management of patients with venous thromboembolism. Arterioscler Thromb Vasc Biol. 2010;30:442-448.
21.
O'Donnell MJ, Kearon C, Johnson J, Robinson M, Zondag M, Turpie I, Turpie AG. Brief communication: Preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin.[Summary for patients in Ann Intern Med. 2007 Feb 6;146(3):I35; PMID: 17283344]. Ann Intern Med. 2007;146:184-187.
22.
Pengo V, Cucchini U, Denas G, Erba N, Guazzaloca G, La Rosa L, De Micheli V, Testa S, Frontoni R, Prisco D, Nante G, Iliceto S, Italian Federation of Centers for the Diagnosis of Thrombosis and Management of Antithrombotic T. Standardized low-molecular-weight heparin bridging regimen
in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study. Circulation. 2009;119:2920-2927. 23.
Robinson M, Healey JS, Eikelboom J, Schulman S, Morillo CA, Nair GM, Baranchuk A, Ribas S, Evans G, Connolly SJ, Turpie AG. Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators. Pacing Clin Electrophysiol. 2009;32:378-382.
24.
Spyropoulos AC, Jenkins P, Bornikova L. A Disease Management Protocol for Outpatient Perioperative Bridge Therapy with Enoxaparin in Patients Requiring Temporary Interruption of Long-Term Oral Anticoagulation. Pharmacotherapy. 2004;24:649-658.
25.
Spyropoulos AC, Frost FJ, Hurley JS, Roberts M. Costs and clinical outcomes associated with lowmolecular-weight heparin vs unfractionated heparin for perioperative bridging in patients receiving long-term oral anticoagulant therapy. Chest. 2004;125:1642-1650.
26.
Spyropoulos AC, Turpie AGG, Dunn AS, Spandorfer J, Douketis J, Jacobson A, Frost FJ, Investigators R. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry. J Thromb Haemost. 2006;4:1246-1252.
27.
Spyropoulos AC, Turpie AGG, Dunn AS, Kaatz S, Douketis J, Jacobson A, Petersen H, Investigators R. Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry). Am J Cardiol. 2008;102:883-889.
28.
Tinmouth AH, Morrow BH, Cruickshank MK, Moore PM, Kovacs MJ. Dalteparin as periprocedure anticoagulation for patients on warfarin and at high risk of thrombosis. Ann Pharmacother. 2001;35:669-674.
29.
Tischenko A, Gula LJ, Yee R, Klein GJ, Skanes AC, Krahn AD. Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin. Am Heart J. 2009;158:252-256.
30.
Tompkins C, Cheng A, Dalal D, Brinker JA, Leng CT, Marine JE, Nazarian S, Spragg DD, Sinha S, Halperin H, Tomaselli GF, Berger RD, Calkins H, Henrikson CA. Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation. J Am Coll Cardiol. 2010;55:23762382.
31.
Varkarakis IM, Rais-Bahrami S, Allaf ME, Lima GC, Permpongkosol S, Rao P, Jarrett TW, Kavoussi LR. Laparoscopic renal-adrenal surgery in patients on oral anticoagulant therapy. J Urol. 2005;174:1020-1023.
32.
Wazni OM, Beheiry S, Fahmy T, Barrett C, Hao S, Patel D, Di Biase L, Martin DO, Kanj M, Arruda M, Cummings J, Schweikert R, Saliba W, Natale A. Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period. Circulation. 2007;116:2531-2534.
33.
Wilson SJ, Morgan J, Gray L, Newman V, Anderson DR. A model for perioperative outpatient management of anticoagulation in high-risk patients: an evaluation of effectiveness and safety. Can J Hosp Pharm. 2001;54:269-277.
34.
Wysokinski WE, McBane RD, Daniels PR, Litin SC, Hodge DO, Dowling NF, Heit JA. Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation.[Erratum appears in Mayo Clin Proc. 2008 Jul;83(7):851]. Mayo Clin Proc. 2008;83:639-645.
Figure Legend Supplemental Figure 1. Search Strategy